Navigation Links
Elusys' Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection
Date:4/22/2008

ntures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
2. Special coating greatly improves solar cell performance
3. Method to deliver molecules within embryonic stem cells improves differentiation
4. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
5. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
6. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
7. Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting
8. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
9. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
10. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
11. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... The endangered black-footed ferret...his rare carnivore feeds on prairie dogs. The pr...n entire population die-offs in towns occur. The ...nted a ferret breeding program and has been releas...ative habitat. Unfortunately, plague can sweep th...
(Date:11/5/2009)...ire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin B... President and CEO of Imagenetix, will be presenti...Conference on Thursday, December 3rd, at 10:30 AM ... LD MICRO ,, LD MICRO is a by-invitation only n... companies in the micro-cap space. Since 2002, the...
(Date:11/5/2009)...y, November 5, 2009 at 4:30 p.m. Eastern Time ,...rstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoG...orted unaudited financial results for the third qu... reviewed the Company,s highlights for the third q...esults reflect the operations of OncoGenex Technol...
(Date:11/5/2009)...Newswire-FirstCall/ -- BioSpecifics Technologies C... developing first-in-class collagenase-based produ... third quarter ended September 30, 2009. ,, "W...year, the FDA,s Arthritis Advisory Committee unani...l of XIAFLEX(TM) for the treatment of Dupuytren,s ...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
... Codexis, Inc. today announced,a licensing agreeme...oduce an,important publicly-undisclosed generic pr...eva, the largest generic drug manufacturer in the ...ct. The product is one of the largest-,selling ge... Under the agreement, Teva would be using the Co...
...tradigm Corporation, a leading,developer of target... today,announced that the company has closed the f...enture Management led the $2.9 million tranche, wi...pating. The addition of these,funds brings the to...m will,use Series B funds to advance its RNAi ther...
...s, Inc. (Nasdaq: ABAX ), a medical products comp...truments for both the medical and veterinary marke...ense agreement for co-exclusive worldwide rights i...ofessional marketplace for certain technologies pe...ethods. , , This license agreement provides Abaxi...
Other Biology Technology:Codexis, Teva in Licensing Agreement Final 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3
(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Critical Zone Observatory seeks to answer climate change questions 10146 1Critical Zone Observatory seeks to answer climate change questions 10146 2Critical Zone Observatory seeks to answer climate change questions 10146 3Critical Zone Observatory seeks to answer climate change questions 10146 4Dr Richard Feinman to speak on the science of diabetes and diet on Oct 2 10142 1
...l known that the bodys energy levels cycle on a 24...olic process is fueled by oxygen. Now, researchers...ine have found that a protein called Rev-erb coord...lecules to maintain the bodys correct metabolism. ...ce Express in advance of print publication in Scie...
...ers at Cincinnati Childrens have issued the first ...blood clotting (fibrin), also plays an important r...f rheumatoid arthritis. Inflammatory joint disease...atory cells with fibrin matrices through a specifi... issue of The Journal of Clinical Investigation, r...
... heck of a commute., The record holder in the Pac...as tagged in the Clearwater River, Idaho, in April...the southern Kuril Islands near Japan. The most di...lies, as they say is 4,200 miles. Imagine fish th...ck to their home streams in order to spawn., The ...
Other Biology News:A mechanism to explain biological 'cross-talk' between 24-hour body cycle and metabolism 2Blood clotting protein linked to rheumatoid arthritis 2UW launches cutting-edge DNA 'fin-printing' project for salmon 2UW launches cutting-edge DNA 'fin-printing' project for salmon 3
Rabbit Anti-KIAA1276 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Cytokeratin 5 / 14 Monoclonal Antibody, Unconjugated, Clone LH8 from Abcam
Rabbit Anti-IL-23 P19 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human C1QC Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: